Medication use in an imperfect world: Drug misadventuring as an issue of public policy, Part 1
The DOI matches its Crossref record.
Abstract
Drug misadventuring is defined, applicable public policy issues are identified and analyzed, and recommendations are suggested for reducing the magnitude and scope of drug misadventuring. The extensive use of pharmaceuticals in the United States, as well as the error-prone systems that are responsible for the appropriate preparation and distribution of drugs, has created new challenges for prescribers, dispensers, and users of drugs. The term "drug misadventuring" covers the broad array of phenomena associated with negative drug experiences. Studies conducted in the United States during the past two decades related to drug misadventuring have been inadequate. Further, extrapolation of data from these studies to the population at large has yielded false projections of the extent of the problem. Since drug misadventuring is a human problem, it is derived from the actions or inactions of a variety of "environments"--social, economic, political, and scientific-technological--that define American society. The following players directly influence decisions associated with drug misadventuring: prescribers, patients, pharmacists, manufacturers, policymakers, and third-party payers. Conflicts of interest among these groups and environmental sectors deter progress in minimizing drug misadventuring. The problem of drug misadventuring must be viewed as a problem in public policy, and new policy decisions must be constructed in the best interest of the patient. Recommendations are made for a "new order" in confronting and resolving this problem. Bold leadership and forthright discussion will be required to find solutions to the problem of drug misadventuring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model
Ernst, F. R., & Grizzle, A. J. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31229-3 · Cited by 849
Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization
Schnipper, J. L., Kirwin, J. L., Cotugno, M. C., Wahlstrom, S. A., Brown, B. A., Tarvin, E., Kachalia, A., Horng, M., Roy, C. L., McKean, S. C., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.5.565 · Cited by 794
ASHP Guidelines on Preventing Medication Errors in Hospitals
Billstein-Leber, M., Carrillo, C. J. D., Cassano, A. T., Moline, K., & Robertson, J. J. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170811 · Cited by 398
Nurses relate the contributing factors involved in medication errors
Tang, F., Sheu, S., Yu, S., Wei, I., & Chen, C. (2007) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01540.x · Cited by 328
The Health Care Cost of Drug-Related Morbidity and Mortality in Nursing Facilities
Bootman, J. L. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440390083011 · Cited by 259
Using bar-code technology and medication observation methodology for safer medication administration
Paoletti, R. D., Suess, T. M., Lesko, M. G., Feroli, A. A., Kennel, J. A., Mahler, J. M., & Sauders, T. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060140 · Cited by 166
Principles of Drug Administration in Renal Insufficiency
Lam, Y. W. F., Banerji, S., Hatfield, C., & Talbert, R. L. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732010-00002 · Cited by 160
Patient Safety and Quality Improvement Act of 2005
Fassett, W. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g485 · Cited by 53
Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone
Ye, J.-H., Ho, Y.-F., On, A. W.-F., Chen, W.-W., Huang, Y.-M., Huang, W.-I., & Tang, Y.-W. (2018) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-0698-5 · Cited by 10
Metadata
- Authors
- Manasse, H. R.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-05-01
- Volume
- 46
- Issue
- 5
- Pages
- 929-944
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W2281334899
- Cited by
- 186
- References
- 0
- FWCI
- 17.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.